C. Glenn Begley, Vice President and Global Head of Hematology and Oncology Research at Amgen, Is Giving a Featured Presentation at the 3rd Cancer Targets and Therapeutics Conference (Feb 27-28, 2012 in Las Vegas, NV)
C. Glenn Begley, Vice President and Global Head of Hematology and Oncology Research at Amgen, will be giving a featured presentation entitled “Challenges in Translating Preclinical Research into Benefit for Patients” at the 3rd Cancer Targets and Therapeutics Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Also presenting at the conference is Jeremy Barton, Vice President of Precision Medicine at Pfizer. Dr. Barton will be speaking on “Patient Selection Strategies for Targeted Therapies and...
View full press release